Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?
Annotations declare the safety profile (readOnly=false, destructive=false, idempotent=false, openWorld=false), so the description is free to add real context — and it does: in-sample only, no holdout, and 'Renvoie les mêmes métriques, limites et quota' sets expectations about results and quota consumption. The lack of any warning about in-sample overfitting risk is a minor gap.
Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.